U
LBMH

UBS’s LIBERATOR MED HLDGS INC (NY) LBMH Stock Holding History

UBS’s Portfolio LBMH Stock Details LBMH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,000
Closed -$15K – 11156
2014
Q2 		$15K Buy
+4,000
New +$15.5K ﹤0.01% 8477

Other funds holding LBMH

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ZIM
ZPR Investment Management Orange City, Florida $46.8M AUM 2.45% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS's LBMH Position: Q3 2014 in Review

UBS increased its LIBERATOR MED HLDGS INC (NY) (LBMH) stake by 279% in Q3 2014, buying an estimated $4.4K and bringing the position to 1,894 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #9379.

UBS first reported a position in LBMH in Q4 2013 and has held it in 4 quarters since. The position peaked at $315K in Q1 2014. 64 funds tracked by Wall St. Rank hold LBMH as of Q3 2014.

  • UBS held 1,894 shares of LIBERATOR MED HLDGS INC (NY) worth $6K as of Q3 2014.
  • UBS bought 1,394 LIBERATOR MED HLDGS INC (NY) shares in Q3 2014, an estimated $4.4K.
  • LIBERATOR MED HLDGS INC (NY) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9379 holding.
  • UBS first reported a position in LIBERATOR MED HLDGS INC (NY) in Q4 2013 and has held it in 4 quarters since.
  • UBS's LIBERATOR MED HLDGS INC (NY) position peaked at $315K in Q1 2014.
  • 64 funds tracked by Wall St. Rank held LIBERATOR MED HLDGS INC (NY) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.